Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABRDN JAPAN EQUITY FUND, INC.JEQ · Entity 74343 | Director | October 10, 2025 | October 14, 2025 |
| abrdn Healthcare InvestorsHQH · Entity 8816 | Director | July 16, 2024 | July 18, 2024 |
| abrdn Healthcare Opportunities FundTHQ · Entity 5102 | Director | July 16, 2024 | July 18, 2024 |
| abrdn Life Sciences InvestorsHQL · Entity 8835 | Director | July 16, 2024 | July 18, 2024 |
| abrdn World Healthcare FundTHW · Entity 5390 | Director | July 16, 2024 | July 18, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABRDN JAPAN EQUITY FUND, INC.
Report date October 10, 2025 · Filed October 14, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-10-10 transaction · row 1
1 source rowRow 1 · 2025-10-10 · Other · Disposed 364 · Balance 0 F1: Effective as of October 10, 2025, abrdn Japan Equity Fund, Inc. (the "Target Fund") was reorganized into the abrdn Global Infrastructure Income Fund. (the "Acquiring Fund," and such reorganization, the "Reorganization"). In the Reorganization, common shareholders of the Target Fund received common shares of the Acquiring Fund having a value equal to the aggregate NAV of the Target Fund common shares surrendered as determined at the close of business on October 10, 2025, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of October 10, 2025, the Target Fund reported a NAV per share of $7.9308 and the Acquiring Fund reported a NAV per share of $29.959. The conversion ratio for the Target Fund's common shares was 0.378399. In the Reorganization, the Reporting Person received 137 common shares of the Acquiring Fund in exchange for her 364 common shares of the Target Fund. |
Filing footnotes · ownership attribution and instrument terms
F1: Effective as of October 10, 2025, abrdn Japan Equity Fund, Inc. (the "Target Fund") was reorganized into the abrdn Global Infrastructure Income Fund. (the "Acquiring Fund," and such reorganization, the "Reorganization"). In the Reorganization, common shareholders of the Target Fund received common shares of the Acquiring Fund having a value equal to the aggregate NAV of the Target Fund common shares surrendered as determined at the close of business on October 10, 2025, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of October 10, 2025, the Target Fund reported a NAV per share of $7.9308 and the Acquiring Fund reported a NAV per share of $29.959. The conversion ratio for the Target Fund's common shares was 0.378399. In the Reorganization, the Reporting Person received 137 common shares of the Acquiring Fund in exchange for her 364 common shares of the Target Fund.
abrdn Healthcare Investors
Report date July 16, 2024 · Filed July 18, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,000 |
Reported balance
After 2024-07-16 transaction · row 1
1 source rowRow 1 · 2024-07-16 · Purchase · Acquired 1,000 · Balance 1,000 |
abrdn Healthcare Opportunities Fund
Report date July 16, 2024 · Filed July 18, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,000 |
Reported balance
After 2024-07-16 transaction · row 1
1 source rowRow 1 · 2024-07-16 · Purchase · Acquired 1,000 · Balance 1,000 |
abrdn Life Sciences Investors
Report date July 16, 2024 · Filed July 18, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,000 |
Reported balance
After 2024-07-16 transaction · row 1
1 source rowRow 1 · 2024-07-16 · Purchase · Acquired 1,000 · Balance 1,000 |
abrdn World Healthcare Fund
Report date July 16, 2024 · Filed July 18, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,000 |
Reported balance
After 2024-07-16 transaction · row 1
1 source rowRow 1 · 2024-07-16 · Purchase · Acquired 1,000 · Balance 1,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 10, 2025 Filed Oct 14, 2025 20:28 UTC | ABRDN JAPAN EQUITY FUND, INC. JEQ · Entity 74343 | OtherCommon Stock | 364 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-099301 · tm2528727-3_4seq1.xml · nonDerivative · entry 1 DiMartino Rose · CIK 0001998932 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Effective as of October 10, 2025, abrdn Japan Equity Fund, Inc. (the "Target Fund") was reorganized into the abrdn Global Infrastructure Income Fund. (the "Acquiring Fund," and such reorganization, the "Reorganization"). In the Reorganization, common shareholders of the Target Fund received common shares of the Acquiring Fund having a value equal to the aggregate NAV of the Target Fund common shares surrendered as determined at the close of business on October 10, 2025, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of October 10, 2025, the Target Fund reported a NAV per share of $7.9308 and the Acquiring Fund reported a NAV per share of $29.959. The conversion ratio for the Target Fund's common shares was 0.378399. In the Reorganization, the Reporting Person received 137 common shares of the Acquiring Fund in exchange for her 364 common shares of the Target Fund. F1 · price: Effective as of October 10, 2025, abrdn Japan Equity Fund, Inc. (the "Target Fund") was reorganized into the abrdn Global Infrastructure Income Fund. (the "Acquiring Fund," and such reorganization, the "Reorganization"). In the Reorganization, common shareholders of the Target Fund received common shares of the Acquiring Fund having a value equal to the aggregate NAV of the Target Fund common shares surrendered as determined at the close of business on October 10, 2025, less the costs of the Reorganization (although cash was distributed for any fractional shares). As of October 10, 2025, the Target Fund reported a NAV per share of $7.9308 and the Acquiring Fund reported a NAV per share of $29.959. The conversion ratio for the Target Fund's common shares was 0.378399. In the Reorganization, the Reporting Person received 137 common shares of the Acquiring Fund in exchange for her 364 common shares of the Target Fund. Read SEC document |
| September 03, 2025 Filed Sep 5, 2025 20:18 UTC | ABRDN JAPAN EQUITY FUND, INC. JEQ · Entity 74343 | Disposition to issuerCommon Stock | 636 | $8.04 | $5,113.44 |
DisclosureSEC source: 0001104659-25-087819 · tm2525320-3_4seq1.xml · nonDerivative · entry 1 DiMartino Rose · CIK 0001998932 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 364 F1 · shares: The amount reported represents the estimated number of shares tendered to the Aberdeen Japan Equity Fund, Inc. (the "Fund") in connection with the issuer tender offer by the Fund pursuant to the Tender Offer Statement on Schedule TO filed with the Securities and Exchange Commission on August 1, 2025 (the "Tender Offer"). The Fund will purchase only a prorated portion of the shares properly tendered by each tendering stockholder. Based on a preliminary count reported by the Fund, the preliminary proration factor is 63.63%. If necessary, an amended Form 4 will be filed to report the number of shares actually disposed of by the reporting person in connection with the Tender Offer once the final proration factor is determined. Read SEC document |
| October 02, 2024 Filed Oct 4, 2024 12:26 UTC | ABRDN JAPAN EQUITY FUND, INC. JEQ · Entity 74343 | PurchaseCommon Stock | 1,000 | $6.19 | $6,190.00 |
DisclosureSEC source: 0001104659-24-106121 · tm2425546-1_4seq1.xml · nonDerivative · entry 1 DiMartino Rose · CIK 0001998932 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| July 16, 2024 Filed Jul 18, 2024 18:54 UTC | abrdn Healthcare Investors HQH · Entity 8816 | PurchaseCommon Stock | 1,000 | $18.88 | $18,880.00 |
DisclosureSEC source: 0001104659-24-080796 · tm2419673-1_4seq1.xml · nonDerivative · entry 1 DiMartino Rose · CIK 0001998932 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| July 16, 2024 Filed Jul 18, 2024 18:56 UTC | abrdn Life Sciences Investors HQL · Entity 8835 | PurchaseCommon Stock | 1,000 | $15.53 | $15,530.00 |
DisclosureSEC source: 0001104659-24-080798 · tm2419673-2_4seq1.xml · nonDerivative · entry 1 DiMartino Rose · CIK 0001998932 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| July 16, 2024 Filed Jul 18, 2024 18:57 UTC | abrdn Healthcare Opportunities Fund THQ · Entity 5102 | PurchaseCommon Stock | 1,000 | $21.30 | $21,300.00 |
DisclosureSEC source: 0001104659-24-080800 · tm2419673-3_4seq1.xml · nonDerivative · entry 1 DiMartino Rose · CIK 0001998932 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| July 16, 2024 Filed Jul 18, 2024 18:58 UTC | abrdn World Healthcare Fund THW · Entity 5390 | PurchaseCommon Stock | 1,000 | $13.31 | $13,310.00 |
DisclosureSEC source: 0001104659-24-080801 · tm2419673-4_4seq1.xml · nonDerivative · entry 1 DiMartino Rose · CIK 0001998932 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.